Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CB-189,625 multiple ascending dose study in healthy male volunteers
NL-OMON37104Active, not recruiting
- Sponsor
- PRA Health Sciences
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of CB-189,625 in acute pain and chronic pain (3 arms), sponsored by PRA Health Sciences. Primary endpoint: Safety and tolerability. Started Oct 2012; status: active, not recruiting.
02
Drugs
CB-189,625
03
Conditions
acute painchronic pain
Beyond the preview
Go deeper on NL-OMON37104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37104.